Pallets Packing | 20'FCL | 40'FCL | ||
With | Without | With | Without | |
25KG/Fibre Drum
|
10 MT
|
--
|
20 MT
|
--
|
CAS No.: | 58-63-9 |
Molecular formula: | C10H12N4O5 |
Molecular weight: | 268.23 |
authentication: | GMP, gyzz h41020149 |
Accreditation: GMP, National pharmaceutical standard H41020149
Quality standards: Chinese Pharmacopoeia (CP)
Level: chemical grade and oral grade (GMP)
Characters: white or whitish crystalline powder
Content: 98.0-102.0%
Test | Specification |
Description | White crystals on crystalline powder,odorless |
Identification | (1) Meet the requirements |
(2) The retention time of sample iscorrespond to std | |
(3) Infrared absorption in accordance with standard atlas | |
Related substances | The total impurities surface area ≤1.0% of the general peek area |
Loss on drying | ≤1.0% |
Residue on ignition | ≤0.2% |
Heavy metals | ≤0.001% |
Assay | 98.0~102.0% |
Limit of microbe | Total bacterial count ≤ 1000CFU/g |
Yeast & Mold ≤ 100CFU/g | |
E.Coil: Negative |
Storage conditions: sealed cool and dry
Primary uses: pharmaceutical drug substance; Use as coenzyme drugs
Inosine is widely used in sports nutrition supplements as it is believed to improve exercise performance and endurance.
Inosine has anti-inflammatory properties, can regulate the immune system's response, and has potential application value in the treatment of some inflammatory diseases.
Inosine can dilate blood vessels, improve blood circulation, and is beneficial for cardiovascular health.
Inosine is used to alleviate some pain conditions, such as arthritis and neuralgia.
Neuroprotection: Inosine has a protective effect in the nervous system and may have some potential for the treatment of neurodegenerative diseases.
Downstream products: inosine patch; Inosine injection